PHARMACOKINETICS OF BUPIVACAINE ENANTIOMERS IN SHEEP - INFLUENCE OF DOSAGE REGIMEN AND STUDY DESIGN

被引:14
作者
MATHER, LE [1 ]
RUTTEN, AJ [1 ]
PLUMMER, JL [1 ]
机构
[1] FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT ANAESTHESIA & INTENS CARE,BEDFORD PK,SA 5042,AUSTRALIA
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1994年 / 22卷 / 06期
关键词
ANESTHETICS LOCAL; BUPIVACAINE; PHARMACOKINETICS; ENANTIOMERS; ADMINISTRATION RATE; DOSAGE REGIMEN;
D O I
10.1007/BF02353791
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bupivacaine is used as a racemate. In previous studies the mean total body clearance of R(+)-bupivacaine was found to be greater than S(-)-bupivacaine by 65% after iv bolus dose of separate enantiomers and by 20% after iv infusion to steady state of racemate. The present studies were performed to determine whether different study designs using different iv dosage regimens could influence the pharmacokinetic parameters determined for either bupivacaine enantiomer. rac-Bupivacaine . HCl was administered iv to 6 adult Merino ewes by bolus, brief infusion, and prolonged infusion. Arterial blood concentrations of R(+)- and S(-)-bupivacaine were measured by enantioselective HPLC. These regimens consistently produced lower arterial blood concentrations of R(+)-bupivacaine than S(-)-bupivacaine due to R(+)-bupivacaine having a greater initial dilution volume by 16 (95% CI = 3-29) %, volume of distribution at steady state equilibrium by 32 (95% CI=17-32)% and mean total body clearance by 28 (95% CI=21-35). The slow half-life of R(+)-bupivacaine, however, was found to be 15 (95% CI=0-31)% longer than that of S(-)-bupivacaine. The difference between enantiomers in mean total body clearance thus was similar to tire previous study based upon infusion to steady state of rac-bupivacaine. Differences in pharmacokinetics attributable to the dosage regimen consisted of a greater mean total body clearance for R(+)-bupivacaine along with a smaller terminal half life with the bolus regimen and a longer half-life of S(-)-bupivacaine after prolonged infusion. Differences in pharmacokinetics between the bupivacaine enantiomers occurred consistently in both distribution and clearance but the magnitude of the effect was less than 50% in each case. Systematic differences in pharmacokinetics associated with the dosage regimen were found mainly in terminal half-life. Dosage regimen, thus, was found to influence the pharmacokinetic results found experimentally and is therefore a significant variable in its own right.
引用
收藏
页码:481 / 498
页数:18
相关论文
共 28 条
[1]   TOXICOLOGICAL AND LOCAL ANESTHETIC EFFECTS OF OPTICALLY ACTIVE ISOMERS OF 2 LOCAL ANESTHETIC COMPOUNDS [J].
ABERG, G .
ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1972, 31 (04) :273-&
[2]   COMPARATIVE PHARMACOKINETICS OF FENTANYL AND ALFENTANIL [J].
BOWER, S ;
HULL, CJ .
BRITISH JOURNAL OF ANAESTHESIA, 1982, 54 (08) :871-877
[3]   CIRCADIAN PHASE-DEPENDENT PROTEIN AND TISSULAR BINDING OF 3 LOCAL-ANESTHETICS (BUPIVACAINE, ETIDOCAINE, AND MEPIVACAINE) IN MICE - A POSSIBLE MECHANISM OF THEIR CHRONOTOXICOKINETICS [J].
BRUGUEROLLE, B ;
PRAT, M .
CHRONOBIOLOGY INTERNATIONAL, 1992, 9 (06) :448-452
[4]   PHARMACOKINETICS OF THE ENANTIOMERS OF BUPIVACAINE FOLLOWING INTRAVENOUS ADMINISTRATION OF THE RACEMATE [J].
BURM, AGL ;
VANDERMEER, AD ;
VANKLEEF, JW ;
ZEIJLMANS, PWM ;
GROEN, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (02) :125-129
[5]   PHARMACOKINETICS OF LIDOCAINE AND BUPIVACAINE FOLLOWING SUBARACHNOID ADMINISTRATION IN SURGICAL PATIENTS - SIMULTANEOUS INVESTIGATION OF ABSORPTION AND DISPOSITION KINETICS USING STABLE ISOTOPES [J].
BURM, AGL ;
VANKLEEF, JW ;
VERMEULEN, NPE ;
OLTHOF, G ;
BREIMER, DD ;
SPIERDIJK, J .
ANESTHESIOLOGY, 1988, 69 (04) :584-592
[6]  
DENSON DD, 1992, REGION ANESTH, V17, P311
[7]   IV BOLUS ADMINISTRATION OF SUBCONVULSIVE DOSES OF LIGNOCAINE TO CONSCIOUS SHEEP - RELATIONSHIPS BETWEEN MYOCARDIAL PHARMACOKINETICS AND PHARMACODYNAMICS [J].
HUANG, YF ;
UPTON, RN ;
RUNCIMAN, WB .
BRITISH JOURNAL OF ANAESTHESIA, 1993, 70 (05) :556-561
[8]   THE IMPORTANCE OF MODELING INTEROCCASION VARIABILITY IN POPULATION PHARMACOKINETIC ANALYSES [J].
KARLSSON, MO ;
SHEINER, LB .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (06) :735-750
[9]   DISPOSITION OF MEPIVACAINE AND BUPIVACAINE ENANTIOMERS IN SHEEP [J].
MATHER, LE .
BRITISH JOURNAL OF ANAESTHESIA, 1991, 67 (03) :239-246
[10]  
MAZOIT JX, 1988, ANESTH ANALG, V67, P961